Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference28 articles.
1. Landscape of neoadjuvant therapy for breast cancer;Haddad;Ann Surg Oncol,2015
2. Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9;Abraham;Breast Cancer Res Treat,2015
3. Neoadjuvant systemic therapy in breast cancer: challenges and uncertainties;Van de Wiel;Eur J Obstet Gynecol Reprod Biol,2016
4. Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy;Chen;Oncotarget,2015
5. HER-2 expression in local advanced breast cancer and the efficacy of neoadjuvant chemotherapy regimens;Dai;J Southern Med Univ,2007
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding Hypoxia-Driven Tumorigenesis: The Interplay of HIF1A, DNA Methylation, and Prolyl Hydroxylases in Head and Neck Squamous Cell Carcinoma;International Journal of Molecular Sciences;2024-06-12
2. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment;Frontiers in Immunology;2024-05-10
3. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis;Systematic Reviews;2024-04-04
4. Combined expression of HIF1α, VEGF and HER2 predicts metastasis, relapse and response to combination chemotherapy in colorectal cancer patients;Annals of Diagnostic Pathology;2023-10
5. The Effectiveness of Radiological Methods in Predicting Pathological Complete Response After Neoadjuvant Therapy in Locally Advanced Breast Cancer Patients;Cukurova Anestezi ve Cerrahi Bilimler Dergisi;2023-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3